GENinCode (LON:GENI) Shares Up 110.2% – Should You Buy?

GENinCode Plc (LON:GENIGet Free Report)’s share price rose 110.2% during mid-day trading on Thursday . The stock traded as high as GBX 6.95 ($0.09) and last traded at GBX 6.73 ($0.08). Approximately 7,091,908 shares traded hands during trading, an increase of 1,322% from the average daily volume of 498,732 shares. The stock had previously closed at GBX 3.20 ($0.04).

GENinCode Price Performance

The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.27. The business has a 50-day moving average of GBX 3.85 and a 200 day moving average of GBX 5.14. The firm has a market capitalization of £8.49 million, a PE ratio of -96.00 and a beta of 0.66.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

See Also

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.